US Patent Issued to Emory University on March 4 for "Combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents" (Georgia Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,239,655, issued on March 4, was assigned to Emory University (Atlanta).

"Combined modalities for nucleosides and/or NADPH oxidase (NOX) inhibitors as myeloid-specific antiviral agents" was invented by Raymond F. Schinazi (Atlanta), Franck Amblard (Atlanta), Christina Gavegnano (Atlanta), Bryan Cox (Atlanta) and Seema Mengshetti (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "Nucleoside compounds, which in some embodiments include an alkynyl substituent at the 4'-position, compositions and methods for treating or preventing HIV and other viral infections, particularly where the virus is present in macrophages, microglia, and primary myeloid cells...